Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism

Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism

Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism

Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.

OBJECTIVE To evaluate the costs and benefits of neonatal screening for phenylketonuria (PKU) and congenital hypothyroidism (CH). Neonatal screening for PKU and CH is common throughout the developed world. It represents a model of preventive care in that the screening procedure is simple and intellectual disability is otherwise irreversible. Changes in treatment and care, and in particular the a...

[Evaluation of the Neonatal Screening Program for congenital hypothyroidism and phenylketonuria in the State of Mato Grosso, Brazil].

OBJECTIVE To evaluate the Reference Center for Neonatal Screening for congenital hypothyroidism and phenylketonuria for the State of Mato Grosso. METHOD Cross-sectional study using secondary data of screening tests carried out from January 2003 to December 2004. RESULTS 66,337 exams were conducted with population coverage of less than 70%. The prevalence of phenylketonuria was 1:33,068 live...

Neonatal screening for congenital hypothyroidism and phenylketonuria in China.

BACKGROUND Neonatal screening is helpful to prevent serious disability and sufferings caused by congenital or inherited disease. This study was to review the status of neonatal screening for congenital hypothyroidism (CH) and phenylketonuria (PKU) in China. METHODS We analyzed data of neonatal screening for CH and PKU in the past two decades which were obtained from the national network of ne...